Evaluation and Surgical Management of Pediatric Cutaneous Melanoma and Atypical Spitz and Non-Spitz Melanocytic Tumors (Melanocytomas): A Report From Children's Oncology Group.

Autor: Sargen MR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD., Barnhill RL; Department of Translational Research, Institut Curie, Unit of Formation and Research of Medicine University of Paris Cité, Paris, France., Elder DE; Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA., Swetter SM; Department of Dermatology/Pigmented Lesion and Melanoma Program, Stanford University Medical Center and Cancer Institute, Stanford, CA., Prieto VG; Departments of Anatomic Pathology and Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX., Ko JS; Department of Anatomic Pathology, Cleveland Clinic, Cleveland, OH., Bahrami A; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA., Gerami P; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL., Karunamurthy A; Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA., Pappo AS; St Jude Children's Research Hospital, Memphis, TN., Schuchter LM; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., LeBoit PE; Departments of Dermatology and Pathology, Helen Diller Family Cancer Center, University of California, San Francisco, San Francisco, CA., Yeh I; Departments of Dermatology and Pathology, Helen Diller Family Cancer Center, University of California, San Francisco, San Francisco, CA., Kirkwood JM; University of Pittsburgh Medical Center Hillman Cancer Center Melanoma Program, Pittsburgh, PA., Jen M; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Section of Pediatric Dermatology, Children's Hospital of Philadelphia, Philadelphia, PA., Dunkel IJ; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY., Durham MM; Department of Surgery, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, GA., Christison-Lagay ER; Division of Pediatric Surgery, Yale School of Medicine, Yale New-Haven Children's Hospital, New Haven, CT., Austin MT; Division of Surgery, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Aldrink JH; Division of Pediatric Surgery, Department of Surgery, Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, OH., Mehrhoff C; Huntsman Cancer Institute, University of Utah Hospital, Salt Lake City, UT., Hawryluk EB; Department of Dermatology, Massachusetts General Hospital, Boston, MA.; Dermatology Program, Department of Allergy and Immunology, Boston Children's Hospital, Boston, MA., Chu EY; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Busam KJ; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Sondak V; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Messina J; Department of Pathology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL., Puig S; Melanoma Unit, Dermatology Department, Hospital Clínic de Barcelona, Instituto de Investigaciones Biomédicas August Pi i Sunye, Universitat de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain., Colebatch AJ; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Coughlin CC; Division of Dermatology, Departments of Medicine and Pediatrics, Washington University School of Medicine in St Louis, St Louis, MO., Berrebi KG; Departments of Dermatology and Pediatrics, University of Iowa Hospitals and Clinics, Iowa City, IA., Laetsch TW; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia and Department of Pediatrics and Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Mitchell SG; Department of Pediatrics, Emory University School of Medicine, Aflac Cancer & Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA., Seynnaeve B; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Oct 04, pp. JCO2401154. Date of Electronic Publication: 2024 Oct 04.

Phase II Study of Samotolisib in Children and Young Adults With Tumors Harboring Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Pathway Alterations: Pediatric MATCH APEC1621D.

Autor: Laetsch TW; Children's Hospital of Philadelphia/University of Pennsylvania, Philadelphia, PA., Ludwig K; University of Texas Southwestern, Dallas, TX., Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD., Roy-Chowdhuri S; University of Texas MD Anderson Cancer Center, Houston, TX., Patton DR; Center for Biomedical Informatics and Information Technology, NCI, NIH, Bethesda, MD., Coffey B; Center for Biomedical Informatics and Information Technology, NCI, NIH, Bethesda, MD., Reid JM; Mayo Clinic Comprehensive Cancer Center, Rochester, MN., Piao J; Keck School of Medicine, University of Southern California, Los Angeles, CA., Saguilig L; Children's Oncology Group Statistical Center, Monrovia, CA., Alonzo TA; Keck School of Medicine, University of Southern California, Los Angeles, CA., Berg SL; Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX., Mhlanga J; Washington University School of Medicine, St Louis, MO., Fox E; St Jude Children's Research Hospital, Memphis, TN., Weigel BJ; University of Minnesota, Minneapolis, MN., Hawkins DS; Seattle Children's Hospital and University of Washington, Seattle, WA., Mooney MM; Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD., Takebe N; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Janeway KA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA., Seibel NL; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Parsons DW; Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX.

Publikováno v: JCO precision oncology [JCO Precis Oncol] 2024 Sep; Vol. 8, pp. e2400258.

A Consensus Statement on the Administration of Systemic Bevacizumab in Patients with Recurrent Respiratory Papillomatosis.

Autor: Best SR; Department of Otolaryngology - Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, U.S.A., Bock JM; Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, U.S.A., Fowler NB; Recurrent Respiratory Papillomatosis Foundation, Lawrenceville, New Jersey, U.S.A., Raabe EH; Division of Pediatric Oncology, Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, U.S.A.; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland, U.S.A., Klein AM; Department of Otolaryngology-Head and Neck Surgery, Emory Voice Center, Emory University School of Medicine, Atlanta, Georgia, U.S.A., Laetsch TW; Department of Pediatrics, Children's Hospital of Philadelphia/University of Pennsylvania, Philadelphia, Pennsylvania, U.S.A., McClellan K; Recurrent Respiratory Papillomatosis Foundation, Lawrenceville, New Jersey, U.S.A., Rinkel RNPM; Department of Otorhinolaryngology/Head and Neck Surgery, Amsterdam UMC, Amsterdam, The Netherlands., Saba NF; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, U.S.A., Sidell DR; Department of Otolaryngology, Head and Neck Surgery, Stanford Children's Health Aerodigestive and Airway Reconstruction Center and Stanford University, Stanford, California, U.S.A., Tansey JB; Recurrent Respiratory Papillomatosis Foundation, Lawrenceville, New Jersey, U.S.A., Tunkel DE; Department of Otolaryngology - Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, U.S.A., Young GD; Recurrent Respiratory Papillomatosis Foundation, Lawrenceville, New Jersey, U.S.A.; Department of Head and Neck Surgery, Miami Cancer Institute, Miami, Florida, U.S.A., Zur KB; Department of Otolaryngology, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, U.S.A.

Publikováno v: The Laryngoscope [Laryngoscope] 2024 Dec; Vol. 134 (12), pp. 5041-5046. Date of Electronic Publication: 2024 Aug 03.

Improving outcomes in pediatric NTRK gene fusion-positive solid tumors: importance of genomic testing and targeted therapy with the TRK inhibitor larotrectinib.

Autor: Laetsch TW; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Center for Childhood Cancer Research and Cancer, Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Publikováno v: Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2024 May; Vol. 22 Suppl 3 (4), pp. 1-11.

Rare Tumors: Opportunities and challenges from the Children's Oncology Group perspective.

Autor: Schultz KAP; Cancer and Blood Disorders, Children's Minnesota, Minneapolis, MN., Chintagumpala M; Division of Hematology-Oncology, Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX., Piao J; University of Southern California Keck School of Medicine, Los Angeles, CA., Chen KS; Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX., Shah R; University of Southern California Keck School of Medicine, Los Angeles, CA.; Division of Hematology-Oncology, Department of Pediatrics, Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA., Gartrell RD; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY., Christison-Lagay E; Yale School of Medicine, Yale New-Haven Children's Hospital, New Haven, CT., Pashnakar F; Department of Pediatrics, Yale University School of Medicine, New Haven, CT., Berry JL; University of Southern California Keck School of Medicine, Los Angeles, CA.; The Vision Center, Children's Hospital Los Angeles, The Saban Research Institute, Children's Hospital Los Angeles, USC Roski Eye Institute, Norris Comprehensive Cancer Center, Los Angeles, CA., O'Neill AF; Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, MA., Vasta LM; Department of Pediatrics, Walter Reed National Military Medical Center, Bethesda, MD., Flynn A; Hematology/Oncology, Children's Mercy Kansas City, Kansas City, MO., Mitchell SG; Aflac Cancer & Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA.; Department of Pediatrics, Emory University, Atlanta, GA., Seynnaeve BK; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA., Rosenblum J; Department of Pediatrics, Division of Pediatric Hematology/Oncology, Westchester Medical Center, New York Medical College, Valhalla, New York, NY., Potter SL; The Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH.; Department of Pediatrics, The Ohio State University, Columbus, OH., Kamihara J; Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, MA., Rodriguez-Galindo C; Departments of Global Pediatric Medicine and Oncology, St. Jude Children's Research Hospital, Memphis, TN., Hawkins DS; Division of Hematology-Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA., Laetsch TW; Division of Oncology, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA.

Publikováno v: EJC paediatric oncology [EJC Paediatr Oncol] 2023 Dec; Vol. 2. Date of Electronic Publication: 2023 Jul 20.